Patent Assignment
Reel/Frame 058686/0886
Assignment of Assignor's Interest
Recorded: 2022-01-19
Pages: 5
Assignor
MCGREGOR, TRACY L.
Executed: 2022-01-18
Assignee
ALNYLAM PHARMACEUTICALS, INC
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(5)
Methods for Inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
Application:
62/532,176 →
Methods for Inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
Application:
62/581,565 →
Methods for Inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
Application:
62/646,285 →
Methods for Inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
Application:
62/682,020 →
Methods For Inhibition Of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 3, 2017
From: ERBE, DAVID V.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 043772/0131 →
Assignment of Assignor's Interest
Feb 7, 2018
From: ERBE, DAVID V.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 044857/0385 →
Assignment of Assignor's Interest
Apr 12, 2018
From: ERBE, DAVID V.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 045527/0591 →
Assignment of Assignor's Interest
Jul 10, 2018
From: ERBE, DAVID V.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 046310/0590 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →